People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their ...

Photodynamic inactivation using curcumin shows promise in reducing antibiotic resistance diversity in Staphylococcus aureus, ...

Frequent interactions between antimicrobial stewardship physicians and pharmacists and use of local antibiotic prescribing ...

Longer antibiotic courses showed no increased benefits or harms than shorter antibiotic courses in older adults, found a ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Leaders of four state agencies on Friday launched a major five-year plan to work together with partners in public health, health care, agribusiness, environmental protection and other fields to ...

In 2017, a tragic incident unfolded in a Nevada hospital. A woman, admitted for pneumonia, tragically succumbed to multiple ...

Overall, 45.8% of COVID-19 hospital admissions and 51.2% of admissions for other respiratory viruses received at least one ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...